Electromed (NSDQ:ELMD) founder, chairman & CEO Robert Hansen relinquished control of the company after 20 years steering the ship.
Kinetic Concepts Inc.
Boston Scientific wins FDA nod for latest pacemaker set
Boston Scientific (NYSE:BSX) said the FDA approved the latest set of its pacemakers, including a device designed to treat patients who can’t regulate their heartbeats while exercising.
The Natick, Mass.-based med-tech maker said the watchdog agency granted pre-market approval for its Ingenio and Advantio pacemakers and for its Invive cardiac resynchronization therapy pacer.
GI Dynamics bolsters commercial team | Personnel Moves
GI Dynamics (ASX:GID) said it hired a trio of new employees to bolster its commercial team as it ramps up sales of its EndoBarrier weight loss device in Europe and Australia.
The Lexington, Mass.-based company said it named Tony Tremaglio senior director of marketing, Anthony Switzer manager of commercial development Down Under and Gerd Gottschalk as reimbursement director for Europe.
Moody’s estimates med-tech tax impact
The 2.3% tax on revenues slated to go into effect next year for medical device makers could top $650 million for the med-tech companies covered by Moody’s Investor Services, according to a report by the ratings agency.
The tax will help slow EBIDTA growth rates for the med-tech sector to between 1% and 4% over the next year to 18 months, according to Moody’s, with organic growth rates of between 2% and 3% during that period.
GMI Ratings adds Boston Scientific to risky bet list | Wall Street Beat
A rating agency specializing in evaluating risky investments added Boston Scientific (NYSE:BSX) to its "Risk List," citing the ongoing fallout from its ill-starred Guidant buyout, its accounting and governance practices and how it pays its executives.
Report: KCI cuts 127 jobs
Kinetic Concepts Inc. (NYSE:KCI) plans to shed 127 workers with the bulk of the cuts occurring at its San Antonio, Tx. facility, according to a report in the San Antonio Express-News.
Mako Surgical names new regulatory VP | Personnel Moves
Mako Surgical (NSDQ:MAKO) tapped Lawrence Gibbons to replace its regulatory affairs vice president, James Keller, who resigned effective Feb. 3.
Gibbons, 60, was most recently with Fisher & Paykel Healthcare (NZE:FPH), where he helped establish a manufacturing facility in Mexico and set up the quality system at the company’s New Zealand headquarters.
MassDevice.com +7 | The top 7 med-tech stories for the week of January 29, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
KCI taps new CEOs, chairman | Personnel Moves
Newly privatized Kinetic Concepts Inc. is shuffling the deck, naming a new chairman, new CEOs for two of its businesses and announcing plans to spin out a third.
The wound care giant was taken private in a $6.1 billion leveraged buyout last year by Apax Partners and a pair of Canadian pension funds.
KCI CEO Burzik bows out ahead of schedule
Kinetic Concepts Inc. (NYSE:KCI) CEO Catherine Burzik, who shepherded the wound care giant through a $6.1 billion leveraged buyout by an Apax Partners-led consortium, plans to step down about 6 months ahead of schedule.
Mela Sciences announces $15M public offering | Funding Roundup
Mela Sciences (NSDQ:MELA) priced a public offering of 5 million shares of common stock at $3.25 per share, hoping to raise up to $14.9 million.
President & CEO Joseph Gulfo and director Robert Coradini agreed to purchase 43,000 shares at the Dec. 15 closing price of $3.97 per share.